Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. DTCA/I, consumer secondary audience
  4. 283 - We are considering a partnership that will allow us to place unbranded, disease awareness information into a variety of large public health portals. The portals contain disease awareness information but also have separate areas that disseminate drug specific information. (We are not providing any drug specific information.) As part of this partnership, we are being offered the ability to have banner ads run throughout the site. The ads are not just for our unbranded content. There is the potential for us to have branded ads that point to our gated product-specific website. The banner ads are "run of site" and there is no influence on where they appear within the portal. There are two possible situations that we are concerned about. Our branded ad appears on a page where our unbranded disease information resides through random placement. Our unbranded disease awareness ad lands on a page which contains related drug information through random placement...
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

283 - We are considering a partnership that will allow us to place unbranded, disease awareness information into a variety of large public health portals. The portals contain disease awareness information but also have separate areas that disseminate drug specific information. (We are not providing any drug specific information.) As part of this partnership, we are being offered the ability to have banner ads run throughout the site. The ads are not just for our unbranded content. There is the potential for us to have branded ads that point to our gated product-specific website. The banner ads are "run of site" and there is no influence on where they appear within the portal. There are two possible situations that we are concerned about. Our branded ad appears on a page where our unbranded disease information resides through random placement. Our unbranded disease awareness ad lands on a page which contains related drug information through random placement...

Scheduled Pinned Locked Moved DTCA/I, consumer secondary audience
1 Posts 1 Posters 305 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • Jennifer CarrollJ Offline
    Jennifer CarrollJ Offline
    Jennifer Carroll
    wrote on last edited by
    #1

    continued ... These situations are out of control but may occur. Does this make us out of compliance with the spirit of the DTC advertising code?

    Response: Generally, in a run of site context, those linkages should occur very rarely in a large/diverse portal (or sets of portals). The same random incidents occasionally occur in print publications. The core principle is that the manufacturer (or its agent) should not take steps to influence the ad environment in such a way that promotes the general public's ability to associate the product with its therapeutic use. Unlikely random incidents which are not under the manufacturer's or agent's control are unlikely to cause the manufacturer to be non-compliant with the consumer advertising regulations. For example, from a statistical perspective, the Arbace ad will appear much more frequently with unrelated condition content (e.g. mood disorders, erectile dysfunction, menopause, pain...etc.) than with disease content relating to its indication (i.e. hypertension).Having said this, these electronic portals provide the opportunity to set exceptions to the run of site command. For example, in my Arbace example, it is simple to allow for run of site except for pages containing the keyword hypertension. Many clients are doing this as a best-practice to make sure their advertising does not contravene (or appear to contravene) the regulations.

    1 Reply Last reply
    0
    Reply
    • Reply as topic
    Log in to reply
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes


    • Login

    • Don't have an account? Register

    • Login or register to search.
    • First post
      Last post
    0
    • Categories
    • Recent
    • Tags
    • Popular
    • Users
    • Groups